DGAP-News: Apricus Biosciences to Provide Overview of Rx and Consumer Healthcare Divisions at the 11th Annual Biotech in Europe Investor Forum
Apricus Biosciences, Inc.
09.09.2011 20:51
—————————————————————————
SAN DIEGO, 2011-09-09 20:51 CEST (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio–) (Nasdaq:APRI)
(http://www.apricusbio.com) announced today that Dr. Bassam Damaj, Chairman,
President and Chief Executive Officer, will present an overview of its
wholly-owned subsidiary, NexMed (USA), Inc.–s Rx and Consumer Healthcare
Divisions, at the 11th Annual Biotech in Euro
